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Multigenotype 
Q Fever Outbreak, 
the Netherlands
To the Editor: Q fever is a 
zoonosis caused by Coxiella burnetii 
(1). An ongoing Q fever outbreak 
has occurred in the Netherlands since 
2007; incidence rates have increased 
>50-fold compared with the baseline 
rate (2). The source of this outbreak 
is unknown. Identifying the source of 
an infection is complicated because 
of difﬁ  culties in obtaining sufﬁ  cient 
clinical and/or environmental samples 
for testing. Molecular diagnosis of Q 
fever has focused on the use of serum 
samples. Up-to-date genotyping of C. 
burnetii has depended on cultivation 
and enrichment of the isolate before 
analysis (3). We report multiple-locus 
variable-number tandem repeat analy-
sis (MLVA) typing of C. burnetii for a 
variety of human and animal clinical 
samples obtained from different loca-
tions in the Netherlands (Table).
Severe pneumonia developed 
in patient 1 after close contact with 
sheep (ewes) and intimate cuddling 
with a newborn lamb. Patients 2 and 3 
(a dairy goat farmer and his wife from 
another village) tested positive for Q 
fever after a large part of their goat 
herd aborted offspring. The farmer 
had no clinical symptoms; his wife had 
mild symptoms that disappeared spon-
taneously within 2 days. No samples 
from any of the goats were available. 
Two additional patients were tested, 1 
of which lived in the same village as 
patients 2 and 3.
Swab specimens from all sheep 
and lambs tested in the ﬁ  rst  case 
yielded identical MLVA genotypes. 
The same genotype was also found 
in patient 1 but not in the other ex-
amined samples, implicating sheep 
as the origin of patient 1’s infection. 
Although patients 2 and 3 lived to-
gether, the genotype found in patient 
2 differed from the (partial) genotype 
found in patient 3. Yet another geno-
type was found in a patient from the 
same village (patient 4). However, an 
identical genotype found in patient 2 
was found in a patient from a distant 
village (patient 5). The village had 
only 1 goat farm, and if this herd of 
goats was the source of infection for 
the farmer, his wife, and patient 4, it 
would have contained >1 genotype. 
At least 1 of the obtained genotypes 
has spread over a wider surface area 
in the Netherlands.
Our results show that the unpre-
cedented, ongoing Q fever outbreak 
in the Netherlands involves multiple 
genotypes of C. burnetii. Because 
most of the genotypes differ only by 
a single repeat difference, they might 
represent microvariants of a hypervir-
ulent strain that has been introduced in 
the Dutch animal population. MLVA 
schemes with up to 17 markers have 
been previously reported (3). In this 
“proof of concept” (applying direct 
genotyping of C. burnetti on clinical 
samples), we focused on the 3 short-
est repeat units because we believed 
that these units might have the highest 
à priori chance of successful ampliﬁ  -
cation in clinical samples (especially 
in serum/plasma). Similar genotypes 
as those reported here were found 
in the MLVA database (http://mlva.
u-psud.fr), but these similarities need 
conﬁ  rmation by using more markers. 
Although using only 3 markers may 
lead to poor discriminatory power, 
we were still able to distinguish 4 dif-
ferent genotypes in a relatively small 
collection of serum samples. We are 
currently exploring the use of addi-
tional MLVA markers. 
Our results also show a poor cor-
relation between DNA load and clini-
cal symptoms. Multiple human and 
animal clinical samples, including 
serum and plasma, throat or genital 
swabs, or sputum and urine, may be 
useful for direct genotyping and out-
break source tracking. 
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Correlation 
between Buruli 
Ulcer and 
Vector-borne 
Notiﬁ  able Diseases, 
Victoria, Australia
To the Editor: Buruli ulcer (BU) 
is a destructive skin disease caused by 
the toxin-producing environmental 
pathogen  Mycobacterium ulcerans. 
Since the 1980s, BU has emerged as 
a major public health problem in ru-
ral West and Central Africa (1), where 
some researchers have suggested a 
role for aquatic insects as either reser-
voirs or vectors of M. ulcerans (2,3). 
However, this hypothesis remains 
unproven (4).
In contrast to the emerging BU–
endemic areas in tropical rural West 
Africa, the climate of the Australian 
state of Victoria is temperate, yet lo-
cally acquired BU also has increased 
there in recent years (5). In addition, 
notiﬁ   cations have varied markedly 
from year to year for reasons not yet 
explained.
During the investigation of a new 
outbreak of BU in Victoria, we dem-
onstrated that M. ulcerans is detect-
able by PCR in mosquitoes and that 
being bitten by mosquitoes increases 
the odds of being diagnosed with BU 
(6,7). However, M. ulcerans–positive 
mosquitoes might reﬂ   ect only the 
presence of M. ulcerans in the local 
environment and play no role in trans-
mission. To further investigate links 
between BU and mosquitoes, we com-
pared patterns of notiﬁ  cations of BU 
with other notiﬁ  able diseases in Vic-
toria. In particular, we were interested 
in any association between BU and 
the locally transmitted vector-borne 
alphaviruses Ross River virus (RRV) 
and Barmah Forest virus (BFV). Ar-
eas of BU and RRV/BFV endemicity 
overlap geographically, but areas with 
RRV and BFV are more extensive and 
include inland river systems where 
BU has not so far been reported.
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Table. Genotyping results for human and animal clinical samples, Q fever outbreak, the Netherlands 
Patient/animal no.  Sample Ms27* Ms28* Ms34* Symptoms  Ct value†  Location
Patient 1  Plasma 3 3 8 Severe 34.4 1
Ewe 1  Vaginal swab  3 3 8 None 25.7 1
Ewe 2  Vaginal swab  3 3 8 None 16.3 1
Ewe 3  Vaginal swab  3 3 8 None 18.8 1
Lamb 1  Throat swab  3 3 8 None 27.9 1
Lamb 2  Throat swab  3 3 8 None 29.9 1
Lamb 3  Throat swab  3 3 8 None 28.9 1
Urine 3 3 7 31.7 Patient 2 
Throat swab  3 3 7
None
31.8
2
Patient 3  Urine NR‡ 3 4 Mild 36.7 2
Patient 4  Sputum 4 3 7 Severe 34.2 2
Patient 5  Sputum 3 3 7 Severe 31.9 3
Nine Mile  Reference strain  4* 6* 5*
*The allele-calling convention used was as published (3), resulting in a 4, 6, 5 code assigned respectively to the 6-bp repeat unit loci Ms-27, Ms-28, and 
Ms-34 for the genome sequence of the Nine Mile RSA-493 strain (GenBank accession no. NC002971.1). Primers for these markers were redesigned to 
amplify significantly shorter PCR products and were combined into 1 multicolor multiplex PCR. Primer sequences for Ms-27 were 5’-HEX-
TCTTTATTTCAGGCCGGAGT-3’ and 5’-GAACGACTCATTGAACACACG-3; for Ms-28, 5’-TMR-AGCAAAGAAATGTGAGGATCG-3’and 5’- 
GCCAAAGGGATATTTTTGTCCTTC-3’; for Ms-34, 5’-FAM-TTCTTCGGTGAGTTGCTGTG-3’ and 5’-GCAATGACTATCAGCGACTCGAA-3’.
†Cycle threshold (Ct) value obtained by using real-time PCR targeting the IS1111a element.  
‡NR, no result obtained. A full genotype was obtained only in samples with the highest DNA loads (Ct value <35).